289 related articles for article (PubMed ID: 11936970)
1. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides.
Bertoni C; Rando TA
Hum Gene Ther; 2002 Apr; 13(6):707-18. PubMed ID: 11936970
[TBL] [Abstract][Full Text] [Related]
2. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides.
Rando TA; Disatnik MH; Zhou LZ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5363-8. PubMed ID: 10805797
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide-mediated gene therapy for muscular dystrophies.
Rando TA
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S55-60. PubMed ID: 12206797
[TBL] [Abstract][Full Text] [Related]
4. Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping.
Bertoni C; Lau C; Rando TA
Hum Mol Genet; 2003 May; 12(10):1087-99. PubMed ID: 12719373
[TBL] [Abstract][Full Text] [Related]
5. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
6. Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs.
Kayali R; Bury F; Ballard M; Bertoni C
Hum Mol Genet; 2010 Aug; 19(16):3266-81. PubMed ID: 20542988
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
Nik-Ahd F; Bertoni C
Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
[TBL] [Abstract][Full Text] [Related]
8. Strand bias in oligonucleotide-mediated dystrophin gene editing.
Bertoni C; Morris GE; Rando TA
Hum Mol Genet; 2005 Jan; 14(2):221-33. PubMed ID: 15563511
[TBL] [Abstract][Full Text] [Related]
9. Cell transplantation and gene therapy in muscular dystrophy.
Morgan JE; Partridge TA
Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
[TBL] [Abstract][Full Text] [Related]
10. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
11. Cell and gene therapy in Duchenne muscular dystrophy.
Morgan JE
Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
[TBL] [Abstract][Full Text] [Related]
12. CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci.
Kapsa RM; Wong SH; Bertoncello I; Quigley AF; Williams B; Sells K; Marotta R; Kita M; Simmons P; Byrne E; Kornberg AJ
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S61-6. PubMed ID: 12206798
[TBL] [Abstract][Full Text] [Related]
13. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
Vilquin JT; Kennel PF; Paturneau-Jouas M; Chapdelaine P; Boissel N; Delaère P; Tremblay JP; Scherman D; Fiszman MY; Schwartz K
Gene Ther; 2001 Jul; 8(14):1097-107. PubMed ID: 11526457
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement.
Kapsa R; Quigley A; Lynch GS; Steeper K; Kornberg AJ; Gregorevic P; Austin L; Byrne E
Hum Gene Ther; 2001 Apr; 12(6):629-42. PubMed ID: 11426463
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
[TBL] [Abstract][Full Text] [Related]
20. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
